Title: URL Source: https://doc.morningstar.com/document/00995d384cc6f481e5e00242df62461f.msdoc?clientid=equiniti&key=118e3421984822cc Markdown Content: # Franklin US Mega Cap 100 UCITS ETF ## IE0008M1R3N4 Large Cap | Factsheet as of 31 May 2025 ## Fund Overview Umbrella Franklin Templeton ICAV Fund Base Currency USD Fund Inception Date 07/05/2025 ISIN IE0008M1R3N4 Valor Number — Domicile Ireland UCITS Yes Product Structure Physical Replication Methodology Full Replication Frequency of Index Reconstitution Quarterly Use of Income Accumulation Fiscal Year End 30 June Shares Outstanding 4,080,000 ## Benchmark(s) and Type Solactive US Mega Cap 100 Select-NR Comparator ## Charges Total Expense Ratio 0.09% The charges are the fees the Fund charges to investors to cover the costs of running the Fund. Additional costs, including transaction fees, will also be incurred. These costs are paid out by the Fund, which will impact on the overall return of the Fund. Fund charges will be incurred in multiple currencies, meaning that payments may increase or decrease as a result of currency exchange fluctuations. Benchmark Fund Fund Characteristics Total Net Assets (USD) $107.61 Million Number of Holdings 101 102 Price to Book 6.23x 6.03x Price to Earnings (12-Month Trailing) 27.81x 27.86x Return on Equity 33.87% 33.89% Dividend Yield 1.10% 1.10% This is a marketing communication. Please refer to the prospectus of the UCITS and to the KID before making any final investment decisions. ## Investment Overview The Fund aims to provide exposure to large capitalisation stocks in the United States. The Fund seeks to track the performance of the Solactive US Mega Cap 100 Select Index-NR (the “Index”) as closely as possible, regardless of whether the Index level rises or falls, while seeking to minimise as far as possible the tracking error between the Fund's performance and that of the Index. ## Performance Under current legislation, we are not allowed to display performance data with less than a complete 12 month performance record. Franklin US Mega Cap 100 UCITS ETF as of 31 May 2025 ## Top Equity Issuers (% of Total) Fund MICROSOFT CORP 9.40 NVIDIA CORP 8.89 APPLE INC 8.18 AMAZON.COM INC 5.40 ALPHABET INC 5.24 META PLATFORMS INC 3.93 BROADCOM INC 3.11 TESLA INC 2.69 JPMORGAN CHASE & CO 2.05 BERKSHIRE HATHAWAY INC 1.86 ## Geographic Allocation (% of Total) Fund Benchmark United States 99.87 97.94 Ireland 0.00 1.47 Switzerland 0.00 0.31 Luxembourg 0.00 0.29 Cash & Cash Equivalents 0.13 0.00 ## Sector Allocation (% of Total) Fund Information Technology 39.39 Financials 13.41 Communication Services 13.20 Consumer Discretionary 11.47 Health Care 10.06 Consumer Staples 5.65 Industrials 2.96 Energy 2.15 Others 1.58 Cash & Cash Equivalents 0.13 ## Market Cap Breakdown (% of Equity) (USD) Fund >50.0 Billion 100.00 ## Trading Information Exchange Ticker Currency Bloomberg Reuters SEDOL Borsa Italiana US100 EUR US100 IM US100.MI BTK0H67 Deutsche Börse Xetra USMC EUR USMC GR USMCG.DE BTLQP26 Euronext Paris Exchange US100 EUR US100 FP US100.PA BTK0H78 London Stock Exchange U100 GBP U100 LN FTU100.L BTRV9B2 London Stock Exchange USMC USD USMC LN FTUSMC.L BTRV990 ## Portfolio Management Years with Firm Years of Experience Dina Ting, CFA 9 29 Lorenzo Crosato, CFA 7 26 What are the Risks? The Fund does not offer any capital guarantee or protection and you may not get back the amount invested. The Fund is subject to the following risks which are materially relevant: Counterparty risk: the risk of failure of financial institutions or agents (when serving as a counterparty to financial contracts) to perform their obligations, whether due to insolvency, bankruptcy or other causes. Index Tracking Risk : No financial instrument or set of investment techniques enables the returns of any Index to be reproduced or tracked exactly. Changes in the investments of any Sub-Fund and re-weightings of the relevant Index may give rise to various transaction costs, operating expenses or inefficiencies which may adversely impact a Sub-Fund's tracking of an Index. Derivative Instruments risk: the risk of loss in an instrument where a small change in the value of the underlying investment may have a larger impact on the value of such instrument. Derivatives may involve additional liquidity, credit and counterparty risks. Index License Risk : To utilise an Index, the Fund may need to have a licence agreement signed with the Index Provider. If, at any time in respect of an Index, the licence granted terminates or disputed, impaired or ceases to exist ,the Directors may be forced to replace the Index with another Index. Such a substitution or any delay in such a substitution may have an adverse impact on the Sub-Fund. Index related risk : the risk that quantitative techniques used in creating the Index the Fund seeks to track do not generate the intended result, or that the portfolio of the Fund deviates from its Index composition or performance. Passive Investment Risk : An Index Tracking Sub-Fund will be negatively affected by general declines in the securities and asset classes represented in its Index. Because Index Tracking Sub-Funds are not "actively" managed, Market disruptions and regulatory restrictions could have an adverse effect on an Index Tracking Sub-Fund's ability to adjust its exposure to the required levels. Foreign Exchange Hedging Risk: Hedging transactions are designed to reduce, as much as possible, the currency risk for investors. No intentional leveraging should result from currency hedging transactions. There is no guarantee that attempts to hedge currency risk will be successful and no hedging strategy can eliminate currency risk entirely. Should a hedging strategy be incomplete or unsuccessful, the value of that Sub-Fund's assets and income can remain vulnerable to fluctuations in currency exchange rate movements. Single Country/Region Risk: This fund invests primarily in Saudi Arabia, which means that it is more sensitive to local economic, market, political or regulatory events in Saudi Arabia, and will be more affected by these events than other funds that invest in a broader range of regions. Equity risk: prices of equities may be affected by factors such as economic, political, market, and issuer-specific changes. Such changes may adversely affect the value of the equities regardless of company-specific performance. Complete information on the risks of investing in the Fund are set out in the Fund's prospectus. Glossary Total Expense Ratio: Total Expense Ratio (TER) includes the fees paid to the management company, the investment manager and the depository, as well as certain other expenses. The TER is calculated by taking the relevant main material costs paid out over the 12-month period indicated and dividing them by the average net assets over the same period. The TER does not include all expenses paid by the fund (for example, it does not include what the fund pays for buying and selling securities). For a comprehensive list of the types of costs deducted from fund assets, see the prospectus. For recent all-in annual costs, as well as hypothetical performance scenarios that show the effects that different levels of return could have on an investment in the fund, where applicable, see the KID. For funds that lack 12 months of data, or for which TER is not likely to give a fair idea of likely future costs, the figure shown is an estimate. Product Structure: The Product Structure indicates whether an ETF is holding physical securities (i.e. Physical) or whether it is tracking the index performance using derivatives (swaps, i.e. Synthetic). Methodology: The Methodology indicates whether an ETF is holding all index securities in the same weight as the index (i.e. Physical Replication) or whether an optimised subset of index securities is used (i.e. Optimised) in order to efficiently track index performance. Comparator: Benchmark is used for comparing Fund performance, but is not a constraint to Fund Investment. Price to Book: The price per share of a stock divided by its book value (i.e., net worth) per share. For a portfolio, the value represents a weighted average of the stocks it holds. Price to Earnings (12-Month Trailing) is the share price of a stock, divided by its per-share earnings over the past year. For a portfolio, the value represents a weighted average of the stocks it holds. Return on Equity: Ameasure of a corporation's profitability that reveals how much profit a company generates with the money shareholders have invested. For a portfolio, the value represents a weighted average of the stocks it holds. Dividend Yield is the annual dividend received on an equity security as a percentage of the price. For a portfolio, the value represents a weighted average of the stocks it holds. It should not be used as an indication of the income received from this portfolio. Portfolio Data Information Holdings are provided for information purposes only and should not be deemed a recommendation to buy or sell the securities mentioned. Franklin US Mega Cap 100 UCITS ETF as of 31 May 2025 Important Information This material is intended to be of general interest only and should not be construed as individual investment advice or a recommendation or solicitation to buy, sell or hold any security or to adopt any investment strategy. It does not constitute legal or tax advice. Special risks are associated with foreign investing, including currency fluctuations, economic instability and political developments; investments in emerging markets involve heightened risks related to the same factors. To the extent the fund focuses on particular countries, regions, industries, sectors or types of investment from time to time, it may be subject to greater risks of adverse developments in such areas at focus than a fund that invests in a wider variety of countries, regions, industries, sectors or investments. For the avoidance of doubt, if you make a decision to invest, you will be buying units/shares in the Fund and will not be investing directly in the underlying assets of the Fund. Franklin Templeton ICAV ("the ETF" or “Fund”) investment returns and principal values will change with market conditions, and an investor may have a gain or a loss when they sell their shares. Please visit www.franklinresources.com/all-sites for the Franklin Templeton ICAV standardised and most recent month-end performance. There is no guarantee that any strategy will achieve its objective. All performance data shown is in the fund's base currency. Performance data is based on the net asset value (NAV) of the ETF which may not be the same as the market price of the ETF. Individual investors may realise returns that are different to the NAV performance. Past performance does not predict future returns . The actual costs vary depending on the executing custodian. In addition, deposit costs may be incurred which could have a negative effect on the value. Please find out the costs due from the respective price lists from the processing/custodian bank. Changes in exchange rates could have positive or negative effects on this investment. Please visit www.franklinresources.com/all-sites to be directed to your local Franklin Templeton website for current performance, and to see the latest Prospectus or Supplement for further details. Information is historical and may not reflect current or future portfolio characteristics. All portfolio holdings are subject to change. The Fund may use financial derivatives or other instruments which entail specific risks more fully described in the Fund's Documents. An investment in the ETF entails risks which are described in the latest Prospectus or Supplement and in the relevant KID. The Fund's documents are available in English, German and French from your local website or can be requested via FT’s European Facilities Service which is available at www.eifs.lu/franklintempleton. In addition, a Summary of Investor Rights is available from www.franklintempleton.lu/summary-of-investor-rights. The summary is available in English. Franklin Templeton ICAV is notified for marketing in multiple EU Member States under the UCITS Directive. Franklin Templeton ICAV can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 93a of the UCITS Directive. Franklin Templeton ICAV (domiciled outside of the U.S. or Canada) may not be directly or indirectly offered or sold to residents of the United States of America or Canada. ETFs trade like stocks, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns. Issued by Franklin Templeton International Services S.à r.l. – Supervised by the Commission de Surveillance du Secteur Financier – 8A, rue Albert Borschette, L-1246 Luxembourg. CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute. Indices are unmanaged, and one cannot invest directly in an index. They do not reflect any fees, expenses or sales charges. Important data provider notices and terms available at www.franklintempletondatasources.com. Solactive AG ("Solactive") is the licensor of Solactive US Mega Cap 100 Select-NR (the “Index”). The financial instruments that are based on the Index are not sponsored, endorsed, promoted or sold by Solactive in any way and Solactive makes no express or implied representation, guarantee or assurance with regard to: (a) the advisability in investing in the financial instruments; (b) the quality, accuracy and/or completeness of the Index; and/or (c) the results obtained or to be obtained by any person or entity from the use of the Index. Solactive does not guarantee the accuracy and/or the completeness of the Index and shall not have any liability for any errors or omissions with respect thereto. Notwithstanding Solactive’s obligations to its licensees, Solactive reserves the right to change the methods of calculation or publication with respect to the Index and Solactive shall not be liable for any miscalculation of or any incorrect, delayed or interrupted publication with respect to the Index. Solactive shall not be liable for any damages, including, without limitation, any loss of profits or business, or any special, incidental, punitive, indirect or consequential damages suffered or incurred as a result of the use (or inability to use) of the Index. In Europe (excluding Switzerland), this financial promotion is issued by Franklin Templeton International Services S.à r.l. - Supervised by the Commission de Surveillance du Secteur Financier - 8A, rue Albert Borschette, L-1246 Luxembourg - Tel: +352-46 66 67-1 - Fax: +352-46 66 76. In Switzerland, issued by Franklin Templeton Switzerland Ltd, Stockerstrasse 38, CH-8002 Zurich. Paying agent in Switzerland is BNP Paribas Securities Services, Paris, succursale de Zurich, Selnaustrasse16, 8002 Zurich. © 2025 Franklin Templeton. All rights reserved.